Abstract:WASHINGTON The hotly debated MX missile program overcam e another challenge yester day as the House voted 217-208 to approve $2.1 billion to p roduce the first 21 o f the in tercontinen tal nuclear weapons. After an hour-long debate in w hich MX advocates said the Reagan adm inistration has made sincere ef forts in arm s contro l and opponents rem ained deeply skeptical, m em bers defeated an am endm ent by Rep. Joseph P. Addabbo, D-N.Y., to strip the production m oney from a $247 billion defense spending bill. The vote was the closest call that the program has had this yeai in the House. M em bers had approved production by a 13-vote margin in a military authorization bill in July and had freed im pounded m oney for the p ro ject by 53 votes in April. Earlier in the afternoon, I he ad ministration chalked up ano ther m ajor gain in its strategic m oder nization program by turning aside, 247-175, an effort by Addabbo to prevent the Air Force from en tering into m ulti-year con tracts for B IB bom bers. It was ano ther indication that the long-debated and once-canceled program will con tinue at full scale. In the MX debate, Rep. Albert Gore, D-Tenn., a leader o f m oderate D em ocrats w ho have been key players in negotiations w ith the ad ministration, ticked off 15 conces sions he said the W hite House made in its arm s-control postu re in re tu rn for support for the MX. “The p residen t so far has lived up to his end of this unp receden ted bar gain, and the C ongress must live up to its end," G ore said. But opponents re iterated their view that the giant, 10 w arhead missiles are dangerous to the nuclear balance and that the nation’s treasury could not afford the ul tim ate $27.5 billion cost for 100 MX “Peacekeepers.” Addabbo w anted to strip $438.7 million in advance p rocurem ent item s for the B-l from the bill and thus p revent the Air Force from being able to com m it itself to bom b er purchases several years in ad vance. Addabbo, chairm an of the House defense appropriations subcom m it tee, said the B IB was not ready for advance procurem ent because the first plane will not fly for a year and operational testing will not he com pleted until after that. By approving multi-year spend ing, he argued, “Congress will be locked into this program and will lose fiscal con tro l” over it. But Rep Jack Edwards, R-Ala., and o th er advocates replied that a Reagan adm inistration pledge to hold the total cost o f the 100-plane B IB program to $20.5 billion in 1981 dollars was contingent on ap proval o f the multi-year feature. “If you give them that excuse to get ou t from u nder that blanket, 1 can’t tell you how m uch the B-l w ould cost,” Edwards said.

Potential Anti-Cancer Activity of a Novel Bi(III) Containing Thiosemicarbazone Derivative

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

In Vitro and in Vivo Anticancer Activities of Bi(III) 2-Thiazolecarboxaldehyde Thiosemicarbazone Complex

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Thiosemicarbazone Mixed-Valence Cu(I/II) Complex against Lung Adenocarcinoma Cells through Multiple Pathways Involving Cuproptosis

Design, Synthesis, And Interaction Study Of Quinazoline-2(1h)-Thione Derivatives As Novel Potential Bcl-X(L) Inhibitors

Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides

Synthesis, crystal structure, and in vitro biological evaluation of bismuth (III) complexes incorporating pyrazinohydrazide‐derived Schiff bases

Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent.

Bismuth(III) bromide-thioamide complexes: synthesis, characterization and cytotoxic properties

Similar co-stimulation requirements of CD4+ and CD8+ primary T helper cells: role of IL-1 and IL-6 in inducing IL-2 secretion and subsequent proliferation.

Biological evaluation of optically pure chiral binuclear copper(ii) complexes based on a rosin derivative as highly potential anticancer agents.

Thiazole Functionalization of Thiosemicarbazone for Cu(II) Complexation: Moving toward Highly Efficient Anticancer Drugs with Promising Oral Bioavailability

Synthesis, Characterization and in Vitro Antitumor Activity of Some Arylbismuth Triphenylgermylpropionates and Crystal Structures of (4-Brc6h4)3bi(o2cch2ch2geph3)2 and (4-Brc6h4)3bi[o2cch(ch3)ch2geph3]2

House vote approves production of first twenty-one MX missiles

Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells

Synthesis, Characterization and Cytotoxicity of Some Triarylbismuth(V) Di(N-P-Toluenesulfonyl) Aminoacetates and the Crystal Structure of (4-Ch3c6h4so2nhch2co2)(2)bi(c6h4cl-(4))(3)

Synthesis and anticancer property of two Sm(III) compounds based on tetrazole ligands

Synthesis and Structure of 5-Methyl-9-(trifluoromethyl)-12H-quino[3,4-b][1,4]benzothiazinium Chloride as Anticancer Agent

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids